Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Simpson

Showing results (271-280 of 275) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 275 results.
The New England Journal of Medicine|December 8, 2015
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A Burger, Alessandra Tedeschi, Paul M Barr, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 29, 2013
Towards a climate-dependent paradigm of ammonia emission and depositionMark A Sutton, Stefan Reis, Stuart N Riddick, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 28

Showing results (271-280 of 275) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 275 results.
The New England Journal of Medicine|December 8, 2015
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaJan A Burger, Alessandra Tedeschi, Paul M Barr, et al.
Blood|January 15, 2017
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Thomas S Uldrick, Adam Bagg, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 29, 2013
Towards a climate-dependent paradigm of ammonia emission and depositionMark A Sutton, Stefan Reis, Stuart N Riddick, et al.
Blood|September 6, 2018
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, Peter Voorhees, Angela Dispenzieri, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 28